MSWM
MRNA icon

Mowery & Schoenfeld Wealth Management’s Moderna MRNA Stock Holding History

Mowery & Schoenfeld Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Hold
700
– – 0.07% 139
2026
Q1 		$35.6K Hold
700
– – 0.05% 144
2025
Q4 		$20.6K Hold
700
– – 0.03% 191
2025
Q3 		$18.1K Hold
700
– – 0.03% 182
2025
Q2 		$19.3K Buy
700
+375
+115% +$9.88K 0.03% 174
2025
Q1 		$9.21K Sell
325
-35
-10% -$1.24K 0.02% 271
2024
Q4 		$15K Sell
360
-340
-49% -$16.3K 0.03% 191
2024
Q3 		$46.8K Hold
700
– – 0.07% 102
2024
Q2 		$83.1K Hold
700
– – 0.12% 71
2024
Q1 		$74.6K Hold
700
– – 0.14% 62
2023
Q4 		$69.6K Buy
+700
New +$58.9K 0.14% 64

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mowery & Schoenfeld Wealth Management's MRNA Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management held its Moderna (MRNA) position steady in Q2 2026 at 700 shares worth $49K. The position accounts for 0.07% of the portfolio, ranked #139.

Mowery & Schoenfeld Wealth Management first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $83.1K in Q2 2024. 424 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Mowery & Schoenfeld Wealth Management held 700 shares of Moderna worth $49K as of Q2 2026.
  • Mowery & Schoenfeld Wealth Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.07% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #139 holding.
  • Mowery & Schoenfeld Wealth Management first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • Mowery & Schoenfeld Wealth Management's Moderna position peaked at $83.1K in Q2 2024.
  • 424 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.